Title:
黄斑変性の治療および管理のための選択的サイトカイン阻害薬の使用方法およびそれを含む組成物
Document Type and Number:
Japanese Patent JP2006509743
Kind Code:
A
Abstract:
Methods of treating, preventing and/or managing macular degeneration are disclosed. Specific embodiments encompass the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Inventors:
Zeldis, Jerome, Bee.
Application Number:
JP2004550274A
Publication Date:
March 23, 2006
Filing Date:
October 31, 2003
Export Citation:
Assignee:
CELGENE CORPORATION
International Classes:
A61K45/00; A61K31/4035; A61K31/409; A61K31/454; A61K31/522; A61K31/545; A61K31/557; A61K31/56; A61K38/18; A61K38/21; A61K38/27; A61K45/06; A61P9/00; A61P9/10; A61P27/02
Domestic Patent References:
| JP2000159761A | 2000-06-13 | |||
| JP2002514578A | 2002-05-21 |
Foreign References:
| US5698579A | 1997-12-16 | |||
| US6020358A | 2000-02-01 | |||
| WO1999006041A1 | 1999-02-11 |
Attorney, Agent or Firm:
Yusuke Hiraki
Ishii Teiji
Satoshi Fujita
Ishii Teiji
Satoshi Fujita
Previous Patent: 抗結核剤であるリファンピシンとβ−シクロデキストリンまたは２−ヒド...
Next Patent: 変化したタンパク質を細胞表面に呈示する腫瘍の診断および処置のための...
Next Patent: 変化したタンパク質を細胞表面に呈示する腫瘍の診断および処置のための...